Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Inflammation and Regeneration is Scopus-indexed (Q1, CiteScore 13.7), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1880-8190Verify ISSN ↗1880-9693Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 23 / 234 | 90th | Q1 |
| Immunology | 26 / 243 | 89th | Q1 |
| Cell Biology | 36 / 289 | 87th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present, best quartile Q1, CiteScore 13.7.
Inflammation and Regeneration is Q1 in Immunology and Allergy (rank 23 of 234), Q1 in Immunology (rank 26 of 243) and Q1 in Cell Biology (rank 36 of 289), by CiteScore 2025.
Inflammation and Regeneration is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.7, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.222, quartile Q1, with an H-index of 49.
The publisher lists an article processing charge of about US$2,577 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Inflammation and Regeneration is published by BioMed Central Ltd. Its print ISSN is 1880-8190 and its online ISSN is 1880-9693.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Inflammation and Regeneration has an h-index of 57 and a 2-year mean of 7.99 citations per paper (OpenAlex). Its Scopus CiteScore is 13.7, quartile Q1. On 2-year citations it ranks #20 of 231 Scopus journals in Immunology and Allergy.
Inflammation and Regeneration published 37 papers in 2025; its busiest recent year was 2022 with 65. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from Japan (63.5%), China (10.9%) and South Korea (5.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.